The trajectory of companies tied to Viagra's legacy presents a complex investment scenario . While the initial surge generated substantial returns , generic alternatives have significantly eroded revenue. https://socialicus.com/story7141485/copyright-s-flagship-product-and-big-pharma-a-uncertain-opportunity